Pregled bibliografske jedinice broj: 384615
Novel derivatives of pyridylbenzo[b]thiophene-2-carboxamides and benzo[b]thieno[2,3-c]naphthyridin-2-ones: minor structural variations provoke major differences of antitumor action mechanisms
Novel derivatives of pyridylbenzo[b]thiophene-2-carboxamides and benzo[b]thieno[2,3-c]naphthyridin-2-ones: minor structural variations provoke major differences of antitumor action mechanisms // Journal of medicinal chemistry, 52 (2009), 8; 2482-2492 doi:10.1021/jm801573v (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 384615 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Novel derivatives of pyridylbenzo[b]thiophene-2-carboxamides and benzo[b]thieno[2,3-c]naphthyridin-2-ones: minor structural variations provoke major differences of antitumor action mechanisms
Autori
Ester, Katja ; Hranjec, Marijana ; Piantanida, Ivo ; Ćaleta, Irena ; Ivana, Jarak ; Pavelić, Krešimir ; Kralj, Marijeta ; Karminski-Zamola, Grace
Izvornik
Journal of medicinal chemistry (0022-2623) 52
(2009), 8;
2482-2492
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
pyridyl-benzo[b]thiophene-2-carboxamides and benzo[b]thieno[2 ; 3-c]naphthyridin-2-ones ; DNA binding ; anticancer activity ; topoisomerase I inhibition ; anti-tubulin activity ; intercalators ; minor groove
(pyridyl-benzo[b] thiophene-2-carboxamides and benzo[b]thieno[2 ; 3-c]naphthyridin-2-ones ; DNA binding ; anticancer activity ; topoisomerase I inhibition ; anti-tubulin activity ; intercalators ; minor groove)
Sažetak
Novel cyano- and 2-imidazolinyl-substituted derivatives of pyridyl-benzo[b]thiophene-2- carboxamides 4, 5, 10-13 and benzo[b]thieno[2, 3-c]naphthyridin-2-ones 6, 7, 14-17 were prepared. All derivatives showed prominent antiproliferative effect. Extensive DNA binding studies and additional biological evaluations point to various modes/targets of action. The results strongly support intercalation into DNA as a dominant binding mode of fused analogues, which was substantiated using topoisomerase I inhibition assay. Most intriguingly, only minor structural difference between non-fused compounds 12 and 13 has strong impact on the interactions with DNA: while 13 binds within the DNA minor groove in the form of dimer, 12 does not form significant interactions with DNA. The assumption that severe mitotic impairment (G2/M phase arrest) induced by 12 could point to another important target-tubulin was confirmed by its obvious anti-tubulin activity observed in immunofluorescence assay, whereby treated cells showed disruption of microtubule formation comparable to the effect obtained by Paclitaxel, well-known tubulin antagonist chemotherapeutic.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
MZOS-098-0982464-2514 - Uloga različitih mehanizama odgovora stanica na terapiju oštećenjem DNA (Kralj, Marijeta, MZOS ) ( CroRIS)
MZOS-098-0982914-2918 - Dizajn, sinteza i ispitivanje interakcija malih molekula s DNA, RNA i proteinima (Piantanida, Ivo, MZOS ) ( CroRIS)
MZOS-125-0982464-1356 - Novi heterocikli kao antitumorski i antivirusni (pametni) lijekovi (Hranjec, Marijana, MZOS ) ( CroRIS)
098-0982464-2393 - Molekularna obilježja miofibroblasta Dupuytrenove bolesti
Ustanove:
Institut "Ruđer Bošković", Zagreb,
Fakultet kemijskog inženjerstva i tehnologije, Zagreb
Profili:
Ivo Piantanida
(autor)
Grace Karminski-Zamola
(autor)
Irena Ćaleta
(autor)
Krešimir Pavelić
(autor)
Ivana Jarak
(autor)
Marijeta Kralj
(autor)
Katja Ester
(autor)
Marijana Hranjec
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- CA Search (Chemical Abstracts)